Adage Capital Partners Gp, L.L.C. Rezolute, Inc. Transaction History
Adage Capital Partners Gp, L.L.C.
- $54.6 Billion
- Q3 2024
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Rezolute, Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 315,845 shares of RZLT stock, worth $1.53 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
315,845
Previous 315,845
-0.0%
Holding current value
$1.53 Million
Previous $1.36 Million
12.74%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding RZLT
# of Institutions
63Shares Held
38.5MCall Options Held
1.6KPut Options Held
24.6K-
Federated Hermes, Inc. Pittsburgh, PA11.3MShares$54.6 Million0.13% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.8MShares$13.5 Million1.99% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.58MShares$12.5 Million0.74% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.93MShares$9.35 Million0.0% of portfolio
-
Blackstone Inc New York, NY1.74MShares$8.44 Million0.04% of portfolio
About Rezolute, Inc.
- Ticker RZLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,827,600
- Market Cap $188M
- Description
- Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultr...